Ping An Biomedical Co., Ltd. (PASW)
NASDAQ: PASW · Real-Time Price · USD
0.1318
0.00 (0.00%)
At close: Apr 2, 2026, 4:00 PM EDT
0.1425
+0.0107 (8.12%)
Pre-market: Apr 6, 2026, 5:06 AM EDT
Ping An Biomedical Revenue
In the fiscal year ending September 30, 2025, Ping An Biomedical had annual revenue of 34.15M CNY, down -61.03%. Ping An Biomedical had revenue of 15.92M in the half year ending September 30, 2025, a decrease of -68.50%.
Revenue (ttm)
34.15M CNY
Revenue Growth
-61.03%
P/S Ratio
3.42
Revenue / Employee
4,878,277 CNY
Employees
7
Market Cap
16.42M USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 34.15M | -53.47M | -61.03% |
| Sep 30, 2024 | 87.62M | 5.06M | 6.13% |
| Sep 30, 2023 | 82.56M | -31.98M | -27.92% |
| Sep 30, 2022 | 114.55M | 15.03M | 15.10% |
| Sep 30, 2021 | 99.52M | 44.06M | 79.43% |
| Sep 30, 2020 | 55.46M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Amazon.com | 716.92B |
| The Home Depot | 164.68B |
| Alibaba Group Holding | 145.37B |
| Tesla | 94.83B |
| QVC Group | 9.50B |
| Rectitude Holdings | 35.77M |
| Millennium Group International Holdings | 25.33M |
| MOGU Inc. | 20.80M |
PASW News
- 17 days ago - All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital - GlobeNewsWire
- 3 months ago - Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry - GlobeNewsWire
- 3 months ago - Ping An Biomedical Co., Ltd. Receives Strategic Investment from Leading Industry Capital, Accelerating Growth in Biopharmaceutical Innovation - GlobeNewsWire
- 4 months ago - Ping An Biomedical Co., Ltd. Announces Receipt of Nasdaq Minimum Bid Price Deficiency Letter - GlobeNewsWire
- 7 months ago - Majestic Ideal Holdings Ltd Announces Approval of Name Change to "Ping An Biomedical Co., Ltd." at Extraordinary General Meeting - GlobeNewsWire
- 9 months ago - Majestic Ideal Holdings Limited Announced Closing of Initial Public Offering - GlobeNewsWire
- 9 months ago - Majestic Ideal Holdings Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq - GlobeNewsWire